This study confirmed the protective effect of melatonin in AD and found that the protective mechanism was related to the regulation of TFEB and the promotion of mitophagy, providing more evidence for the application of melatonin in the treatment of AD. The gene discussed is TFEB; the disease is Alzheimer disease.